Stem Cells and Regenerative Medicine

The regenerative medicine mainly uses stem cells to repair, replace, and regenerate tissues and organs affected by damage, disease, or ageing by restoring its normal function. These regenerative medicine market by the application are oncology, orthopaedic and musculoskeletal spine, wound healing, dermatology, neurodegenerative diseases, cardiovascular, and also in diabetes. The pluripotency and reprograming capability of stem cells increase the importance in this field. The global regenerative medicine market was valued at $5,444 million in 2016 and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. The factors driving the growth of the regenerative medicine market include the emergence of stem cell technology, rise in the incidence of degenerative diseases, and very fewer availability of organs for transplantation.

 

  • Embryonic stem cells
  • Tissue-specific Stem Cells
  • Mesenchymal stem cells
  • Induced pluripotent stem cells

Related Conference of Stem Cells and Regenerative Medicine

February 24-25, 2020

24th Global Congress on Biotechnology

London, UK
June 28-30 2020

Stroke Summit 2020

July 15-16, 2020

12th World Congress and Expo on Stem Cell Research

Prague, Czech Republic
September 23-24, 2020

24th European Biotechnology Congress

Berlin, Germany
October 19-20, 2020

7th Asia Pacific Geriatrics and Gerontology Congress

Tokyo, Japan
October 23-24, 2020

2nd International Conference on Biomarkers and Cancer Targets

Cape Town, South Africa
November 23-24, 2020

International Conference on Toxicogenomics

Bali, Indonesia
December 07- 08, 2020

2nd World Congress on Cell and Structural Biology

Sydney, Australia
December 14-15, 2020

New frontiers in Genetics Research & Advanced Techniques

San Antonio, USA

Stem Cells and Regenerative Medicine Conference Speakers

Recommended Sessions

Related Journals

Are you interested in